安纳达(002136) - 2023 Q3 - 季度财报

Revenue and Profitability - Revenue for Q3 2023 was CNY 573,311,733.89, a decrease of 9.64% compared to the same period last year[5] - Net profit attributable to shareholders was CNY 26,123,622.76, down 64.39% year-on-year[5] - Basic earnings per share for Q3 2023 was CNY 0.1215, a decline of 64.39% compared to the previous year[5] - The net profit for the third quarter of 2023 was CNY 107,211,995, a decrease of 60.19% compared to CNY 269,293,042.99 in the same period last year[10] - Operating profit fell to CNY 97,796,351.17, down 67.46% from CNY 300,524,710.18 year-on-year, primarily due to a decline in the selling prices of titanium dioxide and phosphoric acid[10] - Total revenue decreased significantly, with total profit dropping to CNY 97,403,916.69, a 66.99% decline from CNY 295,087,412.74[10] - The total comprehensive income for Q3 2023 was CNY 107,211,995, compared to CNY 269,293,042.99 in Q3 2022[21] Cash Flow and Financial Position - The company reported a net cash flow from operating activities of -CNY 111,816,904.37, a decrease of 148.06%[5] - The net cash flow from operating activities was negative at CNY -111,816,904.37, a 148.06% decrease compared to CNY 232,637,735.51 in the previous year[11] - Cash and cash equivalents decreased to CNY 384,078,465.93 from CNY 505,920,388.34, indicating a liquidity contraction[16] - The company reported a net cash outflow from operating activities of CNY 111,816,904.37, compared to a net inflow of CNY 232,637,735.51 in the previous year[23] - The company’s cash and cash equivalents at the end of Q3 2023 were CNY 377,578,465.93, a decrease from CNY 453,466,308.88 at the end of Q3 2022[23] Assets and Liabilities - Total assets at the end of Q3 2023 reached CNY 2,035,146,454.26, an increase of 6.46% from the end of the previous year[5] - Total liabilities rose to CNY 569,635,580.67 from CNY 535,848,581.22, reflecting increased financial obligations[17] - Non-current liabilities increased to CNY 10,187,183.52 from CNY 8,756,423.67, indicating a rise in long-term financial commitments[17] - The company's equity attributable to shareholders increased to CNY 1,210,382,132.11 from CNY 1,157,954,662.72, demonstrating improved shareholder value[17] Operational Performance - Total operating costs for the third quarter were CNY 1,530,089,500.04, down from CNY 1,680,882,011.31, reflecting a cost reduction strategy[19] - The company experienced a significant drop in other income, which decreased by 72.15% to CNY 1,708,383.65 from CNY 6,134,129.59[10] - Research and development expenses amounted to CNY 63,624,362, a slight decrease of 3.5% from CNY 65,930,625 in Q3 2022[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 26,727[12] - The largest shareholder, Tongling Chemical Industry Group Co., Ltd., holds 30.00% of the shares, totaling 64,505,784 shares[12] Financial Management - The company reported a 42.51% reduction in management expenses, totaling CNY 19,334,821.75, down from CNY 33,633,404.56[10] - The financial expenses decreased by 54.09%, amounting to CNY -7,075,899.96, compared to CNY -15,412,521.81 in the previous year[10] - The company’s financial expenses showed a significant improvement, with a net financial expense of CNY -7,075,899.96 compared to CNY -15,412,521.81 in Q3 2022[20] Future Outlook - The company plans to focus on market expansion and new product development to drive future growth[18]